Skip to main content
. 2021 Oct 18;9(10):e002998. doi: 10.1136/jitc-2021-002998

Figure 2.

Figure 2

Kaplan-Meier estimates of progression-free survival per Response Evaluation Criteria in Solid Tumors V.1.1 assessed by (A) IRC, (B) investigator, (C) IRC by PD-L1 status (≥1% cut-off), and (D) investigator by PD-L1 status (≥1% cut-off). IRC, independent review committee; PD-L1, programmed death ligand 1.